Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
03-18

DJ Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Regeneron Pharmaceuticals Inc. $(REGN)$ rose 1.73% to $678.42 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.64% to 5,675.12 and the Dow Jones Industrial Average rising 0.85% to 41,841.63.

The stock's rise snapped a four-day losing streak.

Regeneron Pharmaceuticals Inc. closed 43.99% below its 52-week high of $1,211.20, which the company reached on August 27th.

The stock outperformed some of its competitors Monday, as Amgen Inc. $(AMGN)$ rose 1.10% to $317.17, Moderna Inc. $(MRNA)$ rose 0.26% to $34.71, and Gilead Sciences Inc. $(GILD)$ rose 0.74% to $112.26.

Trading volume (942,690) eclipsed its 50-day average volume of 930,725.

Data source: Dow Jones Market Data, FactSet. Data compiled March 17, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

March 17, 2025 16:42 ET (20:42 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10